New England Research & Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
2,548
+567
| +29% | +$230K | 0.49% | 70 |
|
|
2025
Q1 | $986K | Buy |
1,981
+1,246
| +170% | +$620K | 0.5% | 66 |
|
|
2024
Q4 | $382K | Sell |
735
-1,480
| -67% | -$769K | 0.19% | 117 |
|
|
2024
Q3 | $1.37M | Buy |
2,215
+1,075
| +94% | +$665K | 0.64% | 57 |
|
|
2024
Q2 | $630K | Buy |
1,140
+540
| +90% | +$298K | 0.3% | 104 |
|
|
2024
Q1 | $349K | Buy |
+600
| New | +$349K | 0.17% | 133 |
|
|
2020
Q3 | – | Sell |
-2,125
| Closed | -$770K | – | 160 |
|
|
2020
Q2 | $770K | Hold |
2,125
| – | – | 0.55% | 70 |
|
|
2020
Q1 | $603K | Buy |
2,125
+475
| +29% | +$135K | 0.51% | 66 |
|
|
2019
Q4 | $536K | Hold |
1,650
| – | – | 0.36% | 94 |
|
|
2019
Q3 | $481K | Buy |
+1,650
| New | +$481K | 0.35% | 100 |
|